Key points from the Angelini Pharma Satellite Symposia at EEC 2024
Insights from the Angelini Pharma Satellite Symposium at EAN 2024 on avoiding both overtreatment and undertreatment.
Stay up-to-date with the latest research and clinical findings on epilepsy and its treatment strategies.
Insights from the Angelini Pharma Satellite Symposium at EAN 2024 on avoiding both overtreatment and undertreatment.
Insights from the Angelini Pharma Satellite Symposium at EAN 2024 on avoiding both overtreatment and undertreatment.
Podcast about exploring safe and effective use of antidepressants for people living with both epilepsy and depression.
Anxiety affects 35% of newly diagnosed epilepsy patients, highlighting the need for early screening and support.
Epilepsy is linked to a higher risk of diabetes and its complications, emphasizing the need for prevention and better management.
A Bayesian model offers a promising tool to pinpoint seizure focus, potentially improving outcomes for drug-resistant epilepsy surgery.
Machine learning is transforming epilepsy care, aiding in seizure focus detection, outcome prediction, and brain imaging analysis.
Podcast where Prof. Dr. Bernhard Steinhoff addresses how personalised care is transforming epilepsy management.
The STEP survey is providing a number of insights into differing perspectives on seizure control and seizure freedom.
Contact Us
Have a question or want to connect? Find all the ways to connect with Angelini Pharma on our contact page.